Clinical trials
Prognosis clinical trials
Below are recruiting prognosis clinical trials, each written for real people, not researchers. We’re tracking 219 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04224064Recruiting
Blood test to help diagnose and predict liposarcoma
This study looks for a new blood test marker that may help doctors diagnose liposarcoma and estimate how it may behave over time. You may be asked for a blood sample and consent, and the study may follow you to see how well the test works.
MontpellierAges 18 years+ - NCT07396662Recruiting
Pancreas Function and Recovery After Surgery
This study looks at how well the pancreas works (both hormone and digestive functions) and what happens to patients after pancreas removal surgery. It may help doctors better predict recovery and long-term health.
Taipei, TaiwanAges 20–75 - NCT07381803RecruitingPhase 3
Fexofenadine for heart attack recovery
This trial tests if the allergy medicine fexofenadine can improve recovery after a heart attack. You may qualify if you had a specific type of heart attack (STEMI) within the last week.
Hangzhou, ZhejiangAges 18 years+ - NCT06624488Recruiting
Brain injury markers after cardiac arrest and outlook
This study looks at certain proteins in the fluid around the brain and in the blood after a cardiac arrest. These proteins may help doctors predict how the patient will recover, which could guide their care.
BeijingAges 18–80 - NCT06771960Recruiting
Targeted therapy before surgery for EGFR lung cancer
This trial looks at how well a targeted therapy works before surgery for people with EGFR-mutated non-small cell lung cancer. It aims to understand the link between a heart rhythm measure (RVT) and patient outcomes.
Guangzhou, GuangdongAges 18–80 - NCT07375433Recruiting
Heart failure and COPD study for patients aged 50 to 70
This trial looks at how heart failure with preserved pumping function affects people who also have COPD. It aims to understand the course of the disease and long-term outlook.
Kazan'Ages 50–70 - NCT05339451Recruiting
Blood and tissue tests to improve endometriosis diagnosis
This study collects blood and small tissue samples during planned gynecological surgery to better diagnose endometriosis and predict its course. It may help future patients by making diagnoses and outlook more accurate.
Stockholm, HuddingeAges 18–45 - NCT07378176Recruiting
Study on outlook for primary aldosteronism patients
This study follows people with primary aldosteronism over time to understand their health outcomes. It may help doctors learn how to better treat this condition.
Chengdu, SichuanAges 18–80 - NCT07378631Recruiting
Chronic radiation bowel disease study
This study looks at how different types of chronic radiation enteropathy, a bowel condition caused by radiation therapy, are linked to patient outcomes. It may help doctors better predict how the condition progresses.
Guangzhou, GuangdongAges 18–80 - NCT05477979Recruiting
Study how stress affects lung cancer treatment outcomes
This study looks at whether psychological stress changes how well lung cancer treatments work and what the outlook is. You may qualify if you’re about to start (or recently started) certain immunotherapy-based treatments, and you can complete stress and well-being questionnaires.
Changsha, HunanAges 18 years+ - NCT06387225Recruiting
Study on brain recovery after cardiac arrest
This study is trying to find better ways to predict recovery in people who had a cardiac arrest outside the hospital and are still unconscious in the intensive care unit. It may help doctors give more accurate information to families.
La Roche-sur-YonAges 18 years+ - NCT07354568Recruiting
Mixed heart and blood vessel shock study
This study looks at people with a severe type of shock that affects both the heart and blood vessels, treated in the intensive care unit. It aims to understand how these patients recover and what factors impact their survival.
Amiens, SommeAges 18 years+ - NCT07345169Recruiting
Immune and inflammation study in ICU patients
This study looks at how your immune system and inflammation affect your recovery in the intensive care unit. Researchers want to understand why some patients do better than others.
ParisAges 18 years+ - NCT07335770Enrolling by invitation
Heart MRI for diagnosing and managing heart masses
This trial uses cardiac MRI to better understand heart masses (tumors or clots) and guide treatment decisions. It may help determine what the mass is and how it affects your health.
Ages Any age - NCT07338539Recruiting
Shorter radiation for poor-prognosis GBM
This trial tests a shorter course of radiation (hypofractionated RT) for people with a specific type of aggressive brain tumor (GBM) that is not suitable for surgery. It aims to see if this shorter treatment can be effective with fewer side effects.
Mumbai, MaharashtraAges 50 years+ - NCT07322627Recruiting
Esophageal cancer genetics and treatment outlook study
This study looks at a specific gene (ALDH2) in people with esophageal cancer to see if it affects how well they respond to treatment. It may help doctors better predict outcomes and personalize care.
TaipeiAges 18–99 - NCT07311356Recruiting
Understanding early-onset anorexia prognosis
This study looks at the long-term outcomes for children hospitalized for anorexia nervosa. It aims to help doctors and families better understand the disease and improve care.
ParisAges birth–30 years - NCT06738758Recruiting
Early intensive cholesterol-lowering study for acute coronary syndrome
This study tests whether starting strong cholesterol-lowering treatment early in the hospital can improve outcomes for people with acute coronary syndrome (a serious heart condition like a heart attack or unstable angina). It may help if you have high LDL cholesterol.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06803784Recruiting
Bioproducts in body fluids for early brain disease detection
This study is looking for proteins in blood and other body fluids that could help detect brain diseases like Parkinson's, Alzheimer's, and ALS early. It aims to improve diagnosis and future treatments.
Pozzilli, ItalyAges 20 years+ - NCT07280585RecruitingPhase 3
Testing a diabetes drug to slow kidney disease progression
This study tests whether a common diabetes medication (SGLT2 inhibitor) can help people with autosomal dominant polycystic kidney disease (ADPKD) maintain kidney function longer. If you have fast-growing kidney cysts and are between 18 and 60 years old, this trial may be an option.
FeldkirchAges 18–60 - NCT04606732Recruiting
Tracking heart risk changes after COVID-19 hospitalization
This study looks at how COVID-19 affects heart health over time in people who were hospitalized. Your results may help doctors predict prognosis and understand who is at higher heart risk after recovery.
BolognaAges 18 years+ - NCT07262515Recruiting
Blood tests and genes for alcoholic hepatitis recovery
This study looks at blood samples and genetic information from people with acute alcoholic hepatitis to understand why some recover better than others. It aims to find better ways to predict and improve outcomes.
ParisAges 18 years+ - NCT07263204Recruiting
AI for diagnosing and predicting hypertrophic cardiomyopathy
This trial uses artificial intelligence to help diagnose and predict outcomes for people with hypertrophic cardiomyopathy (HCM), a condition where the heart muscle becomes thickened. It may help doctors better understand your condition and plan your care.
Hangzhou, ZhejiangAges 18 years+ - NCT06898307Recruiting
Genetic test study for inherited heart rhythm conditions
This study uses genetic testing to better diagnose, predict, and manage inherited heart rhythm diseases. It is designed for patients at the University of Ferrara's Cardiogenetic Center who have a confirmed genetic heart condition.
FerraraAges Any age
Hear when a new Prognosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for prognosis?
- Yes. Clin2 currently lists 219 recruiting prognosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a prognosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a prognosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.